TAIPEI (Taiwan News) — Taiwan is intensifying efforts in generic drug development to strengthen the global competitiveness of its pharmaceutical industry, with 11 local firms currently participating ...
The US Food and Drug Administration (FDA) is committed to helping facilitate American patients’ access to lower-cost generic medicines by taking steps to enhance and streamline the development and ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
The government has initiated a sweeping overhaul of the drug pricing system to lower the prices of generic drugs, which have been criticized for being more expensive than international standards. The ...
The Generic Drugs Market has emerged as one of the most critical segments of the global pharmaceutical industry due to its ability to provide affordable and effective alternatives to branded ...
(MENAFN- GlobeNewsWire - Nasdaq) The global generic drug CRO market size was valued at USD 8.45 billion in 2024 and is predicted to hit around USD 11.73 billion by 2034, rising at a 3.36% CAGR, a ...
At the Health Insurance Policy Deliberation Committee meeting on the 28th, the Ministry of Health and Welfare's drug pricing reform plan is expected to be tabled. In particular, as the likelihood ...
Viatris Inc. (NASDAQ:VTRS), a prominent player in the biopharmaceutical industry with a market capitalization of $9.73 billion, finds itself navigating a complex landscape of challenges and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results